Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin for Urogenital Chlamydia in Males in Youth Correctional Facilities
NCT03249935Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Aug 2017
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of azithromycin in urogenital chlamydia infection, sponsored by National Institute of Allergy and Infectious Diseases. Started Aug 2017; status: completed.
02
Drugs
azithromycin
03
Conditions
urogenital chlamydia infection
Beyond the preview
Go deeper on NCT03249935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03249935.